메뉴 건너뛰기




Volumn 49, Issue 12, 2011, Pages 4158-4163

Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: A Spanish multicenter prospective survey

(14)  Pemán, Javier a   Cantón, Emilia a   Linares Sicilia, María José b   Roselló, Eva María c   Borrell, Nuria d   Ruiz Pérez de Pipaon, María Teresa e   Guinea, Jesús f   García, Julio g   Porras, Aurelio h   García Tapia, Ana María i   Pérez del Molino, Luisa j   Suárez, Anabel k   Alcoba, Julia l   García García, Inmaculada m  


Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

EID: 82455186866     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05474-11     Document Type: Article
Times cited : (64)

References (26)
  • 2
    • 78650859229 scopus 로고    scopus 로고
    • National surveillance of fungemia in Denmark (2004 to 2009)
    • Arendrup, M. C., et al. 2011. National surveillance of fungemia in Denmark (2004 to 2009). J. Clin. Microbiol. 49:325-334.
    • (2011) J. Clin. Microbiol. , vol.49 , pp. 325-334
    • Arendrup, M.C.1
  • 3
    • 66149142200 scopus 로고    scopus 로고
    • Not just little adults: Candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients
    • Blyth, C. C., et al. 2009. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 123:1360-1368.
    • (2009) Pediatrics , vol.123 , pp. 1360-1368
    • Blyth, C.C.1
  • 6
    • 52049116112 scopus 로고    scopus 로고
    • The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy
    • Hachem, R., H. Hanna, D. Kontoyiannis, Y. Jiang, and I. Raad. 2008. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 112:2493-2499.
    • (2008) Cancer , vol.112 , pp. 2493-2499
    • Hachem, R.1    Hanna, H.2    Kontoyiannis, D.3    Jiang, Y.4    Raad, I.5
  • 7
    • 79955898005 scopus 로고    scopus 로고
    • European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: Summary of the ECIL 3-2009 update
    • Maertens, J., et al. 2010. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 update. Bone Marrow Transplant. 46:709-718.
    • (2010) Bone Marrow Transplant , vol.46 , pp. 709-718
    • Maertens, J.1
  • 8
    • 77953215487 scopus 로고    scopus 로고
    • Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients
    • Neofytos, D., et al. 2010. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl. Infect. Dis. 12:220-229.
    • (2010) Transpl. Infect. Dis. , vol.12 , pp. 220-229
    • Neofytos, D.1
  • 9
    • 58749083534 scopus 로고    scopus 로고
    • Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry
    • Neofytos, D., et al. 2009. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin. Infect. Dis. 48:265-273.
    • (2009) Clin. Infect. Dis. , vol.48 , pp. 265-273
    • Neofytos, D.1
  • 10
    • 70249138029 scopus 로고    scopus 로고
    • Epidemiology of candidemia at a children's hospital, 2002 to 2006
    • Neu, N., et al. 2009. Epidemiology of candidemia at a children's hospital, 2002 to 2006. Pediatr. Infect. Dis. J. 28:806-809.
    • (2009) Pediatr. Infect. Dis. J. , vol.28 , pp. 806-809
    • Neu, N.1
  • 11
    • 60549098868 scopus 로고    scopus 로고
    • Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
    • Pappas, P. G., et al. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
    • (2009) Clin. Infect. Dis. , vol.48 , pp. 503-535
    • Pappas, P.G.1
  • 13
    • 79955605427 scopus 로고    scopus 로고
    • Variación de la epidemiologia de las fungemias y de la sensibilidad a fluconazol de los aislamientos en los últimos 10 años en España: Resultados del estudio FUNGEMYCA
    • Pemán, J., et al. 2011. Variación de la epidemiologia de las fungemias y de la sensibilidad a fluconazol de los aislamientos en los últimos 10 años en España: resultados del estudio FUNGEMYCA. Rev. Iberoam. Micol. 28:91-99.
    • (2011) Rev. Iberoam. Micol. , vol.28 , pp. 91-99
    • Pemán, J.1
  • 14
    • 13144253140 scopus 로고    scopus 로고
    • Epidemiology and antifungal susceptibility of Candida species isolated from blood: Results of a 2-year multicentre study in Spain
    • DOI 10.1007/s10096-004-1267-5
    • Pemán, J., E. Cantón, and M. Gobernado. 2005. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 24:23-30. (Pubitemid 40179128)
    • (2005) European Journal of Clinical Microbiology and Infectious Diseases , vol.24 , Issue.1 , pp. 23-30
    • Peman, J.1    Canton, E.2    Gobernado, M.3
  • 15
    • 79959193758 scopus 로고    scopus 로고
    • Clinical breakpoints for voriconazole and Candida spp. revisited: Review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
    • Pfaller, M. A., et al. 2011. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn. Microbiol. Infect. Dis. 70:330-343.
    • (2011) Diagn. Microbiol. Infect. Dis. , vol.70 , pp. 330-343
    • Pfaller, M.A.1
  • 16
    • 77957893941 scopus 로고    scopus 로고
    • Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
    • Pfaller, M. A., D. Andes, D. J. Diekema, A. Espinel-Ingroff, and D. Sheehan. 2010. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist. Updat. 13:180-195.
    • (2010) Drug Resist. Updat. , vol.13 , pp. 180-195
    • Pfaller, M.A.1    Andes, D.2    Diekema, D.J.3    Espinel-Ingroff, A.4    Sheehan, D.5
  • 17
    • 33846466508 scopus 로고    scopus 로고
    • Epidemiology of invasive candidiasis: A persistent public health problem
    • DOI 10.1128/CMR.00029-06
    • Pfaller, M. A., and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163. (Pubitemid 46167771)
    • (2007) Clinical Microbiology Reviews , vol.20 , Issue.1 , pp. 133-163
    • Pfaller, M.A.1    Diekema, D.J.2
  • 18
    • 74949107171 scopus 로고    scopus 로고
    • Epidemiology of invasive mycoses in North America
    • Pfaller, M. A., and D. J. Diekema. 2010. Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol. 36:1-53.
    • (2010) Crit. Rev. Microbiol. , vol.36 , pp. 1-53
    • Pfaller, M.A.1    Diekema, D.J.2
  • 19
    • 79955538785 scopus 로고    scopus 로고
    • Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretative criteria
    • Pfaller, M. A., et al. 2011. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretative criteria. Drug Resist. Updat. 14:164-176.
    • (2011) Drug Resist. Updat. , vol.14 , pp. 164-176
    • Pfaller, M.A.1
  • 20
  • 21
    • 78650924029 scopus 로고    scopus 로고
    • Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: Report from the SENTRY antimicrobial surveillance program (2008 to 2009)
    • Pfaller, M. A., G. J. Moet, S. A. Messer, R. N. Jones, and M. Castanheira. 2011. Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY antimicrobial surveillance program (2008 to 2009). J. Clin. Microbiol. 49:396-399.
    • (2011) J. Clin. Microbiol. , vol.49 , pp. 396-399
    • Pfaller, M.A.1    Moet, G.J.2    Messer, S.A.3    Jones, R.N.4    Castanheira, M.5
  • 23
    • 0028950634 scopus 로고
    • Candidemia in a pediatric population
    • Stamos, J. K., and A. H. Rowley. 1995. Candidemia in a pediatric population. Clin. Infect. Dis. 20:571-575.
    • (1995) Clin. Infect. Dis. , vol.20 , pp. 571-575
    • Stamos, J.K.1    Rowley, A.H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.